Esperion Therapeutics Revenue, Growth & Competitor Profile

DBA ESPERION

Company Profile & Annual Report for Esperion Therapeutics

Access the complete profile.

Esperion Therapeutics Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	3891 Ranchero Drive, Suite 150 Ann Arbor, MI 48108

Note: Revenues for privately held companies are statistical evaluations.


Esperion Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Esperion Therapeutics's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Esperion Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Esperion Therapeutics Annual Revenue and Growth Rate

Esperion Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Esperion Therapeutics's revenues are gauged from an analysis of company filings.

Esperion Therapeutics's Income Statement (based on Industry Averages)

Esperion Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Esperion Therapeutics is developing and marketing. Esperion Therapeutics doesn't have any recent trademark applications, indicating Esperion Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
NEXLIZET pharmaceutical preparations for the treatment of metabolic disease	10/05/2018
NEXLETOL pharmaceutical preparations for the treatment of metabolic disease	03/23/2018
BEYOND STATINS Pharmaceutical preparations for the treatment of cardiovascular and metabolic diseases	06/15/2012

See all trademarks and details in the Full Report.

Market Share of Esperion Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Esperion Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Esperion Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ASH STEVENS	Riverview, MI	100
ESPERION THERAPEUTICS	Ann Arbor, MI	11
BRYLLAN	Brighton, MI	4
SIERRA ONCOLOGY	Plymouth, MI	4
UNITED SPECIALTY PHARMACY	Dearborn, MI	1
PHARMACEUTICAL CARE SOLUTIONS	Ann Arbor, MI	1

Future Competition: Esperion Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Esperion Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)